FREE TO IN-HOUSE COUNSEL
EUROPEAN LIFE SCIENCESFORUM 2018APRIL 24, LE MÉRIDIEN PICCADILLY LONDON
REGISTRATIONS
+44 207 779 8938
PROGRAMME
+44 207 779 8730
SPONSORSHIP
+44 207 779 8836
W W W. M A N A G I N G I P. C O M / E U R O L I F E S C I E N C E S 1 8# E U L I F E S C I E N C E S 1 8
SPONSORSSUPPORT ING ORGANISAT IONS
EUROPEAN L IFE SCIENCESFORUM 2018APRIL 24, LE MÉRIDIEN PICCADILLY LONDON
INTRODUCTIONThe life sciences industry is one of the most complex, contentious and rapidlydeveloping fields. In order to prepare for Brexit and the forecasted uncertainty,companies need to ensure their portfolio is sustainable, flexible and robust to man-age IP and regulatory enforcement over the coming months.
The second annual MIP European Life Sciences Forum will identify the key uniquechallenges faced by life sciences companies. The forum will provide tips for devel-oping a comprehensive strategy in order to promote commercial growth andrespond to the patent challenges of an uncertain and evolving legislative land-scape. Topics will include: Doctrine of equivalents and the impact of the decisionacross your European portfolio; application of issues surrounding the use of Arrowdeclarations and; patent protection strategies involving divisionals.
The programme addresses the major issues at hand and will encourage participa-tion and debate on all of the pertinent topics from the varied perspectives. The MIPEuropean Life Sciences Forum 2018 will bring together world leaders in corpora-tions, industry associations and leading legal experts to analyse strategies toensure your company is prepared to thrive in the forecasted uncertain political cli-mate.
Register your place today.
BENEFITS OFATTENDINGDelegates are invited to attend a fullday of debates and discussions tohear from, and network with, leadingexperts from multiple jurisdictions. Alldelegates will be party to importantdebates about the most significantdevelopments in the global patentlandscape over the past year, with theopportunity to contribute as well aslearn
• Hear how you should be rethinkingyour European strategy inpreparation for Brexit
• Listen to essential case updates andconsiderations when enforcingsecond medical use claims
• Discuss the application of thedoctrine of equivalents and theimpact on life sciences companies
• Learn from companies onapplication of the issues surroundingArrow declarations
• Identify and overcome the challengesof enforcing your SPC’s
• Learn best practice to manage theglobal threat caused by counterfeitdrugs
• Join analysis on the trends that areinfluencing litigation of biosimilars inEU, UK & US
• Examine the implications of AI andhow it is being used in thedevelopment of medicine
WHO YOU WILLMEET• IP in-house counsel• Patent/Trade mark
counsel/Attorneys• IP counsel and IP managers• VP/SVP Patents• General counsel• Corporate counsel • Private practice lawyers• Heads/Directors of IP, patents &
Legal affairs
SPONSORSHIP OPPORTUNITIESWe will create a bespoke solution that will position your organisation as athought leader and ensure you engage with your target audience. The willhelp you to meet and influence the people who are going to grow yourbusiness. Please contact Melanie Petch on +44 207 779 [email protected] to discuss.
TO REGISTER, OR FOR MORE INFORMATIONPLEASE CALLKEVIN PRAGAS: +44 207 779 8938EMAIL: [email protected]
FOR IN-HOUSE SPEAKING OPPORTUNITIESPLEASE CONTACTNATALIE CANTER: +44 207 779 8730 EMAIL: [email protected]
EUROPEAN L IFE SCIENCESFORUM 2018APRIL 24, LE MÉRIDIEN PICCADILLY LONDON
PROGRAMME
9:00 Registration
9:30 Opening remarks by Michael Loney, managing editor,Managing IP
9:40 Keynote address: Insight from big Pharma: how can IPleaders drive innovations that will bring value to patients andshareholders, changing global views on IP, innovation andaccess? Aaron Smethurst, director, intellectual property policy,UCB Pharma
10:00 Responding to the key challenges in life sciences to promotecommercial growth
• Rethinking your European strategy in preparation of Brexit• What does Brexit mean for cross-border litigation? • The Unified Patent Court – final preparations for 2018• Assessing latest trends in preliminary injunctions across Europe
Annemarie Grabrucker, lawyer, European Patent Office (moderator)Amarjit Purewal, solicitor, Cancer Research TechnologyFrancesco Macchetta, director of IP, Bracco
10:40 Coffee break and networking
11:00 Defending second medical use patents in multi-jurisdictions
• Examining the impact of recent litigation: Lyrica• To what extent should you be investigating opportunities for
new uses of existing medicines?• Considerations and tips when choosing where to enforce your
second medical use claim• Solutions to overcome cross-labelling infringement
Philipp Cepl, partner, DLA PiperBeatriz Díaz de Escauriaza, senior IP counsel, Chemo Pharma
11:40 Patent infringement by equivalents
• Application of the doctrine of equivalents– what does thejudgement mean in practice?
• What impact will the doctrine have on life sciencescompanies?
• Doctrine of equivalence across Europe: analysing differentapproaches
• To what extent are we moving towards harmonisation?
Dieter Kuhn, senior patent attorney, DSMJody Giesser, senior patent counsel, DSM
12:20 Lunch and networking
13:20 Scope of SPC regulations and patent maximisation
• Identifying and overcoming the challenges of enforcing yourSPC’s
• Applying SPC regulation across different European jurisdictions• The need for legal and business certainty - is the regulation still
fit for purpose?• Case focus: Mylan v Gilead
Marianne Schaffner, partner, DentonsCampbell Forsyth, partner, Dentons
14:00 Arrow declarations: beyond biosimilars
• Application of issues surrounding Arrow declarations• To what extent can you receive declarations for the invalidity of
pending patents• Analysing European approaches to declaratory relief• Impact of Supreme Court in Pemetrexed on declaratory relief
Jenny Davies, principal associate, Gowling WLGJason Rutt, patent attorney, Boult Wade Tennant
14:40 Coffee break and networking
15:00 Recent approaches to pharma litigation in Russia
• Preparing your IP litigation strategy: who can be sued and forwhat? Novartis v Nativa
• Patent linkage: does it work in Russia?• Challenging PTE: a counter-measure of infringers- Pfizer v
Canonpharma• Compulsory license: a new defense against infringement
actions
Natalia Nikolaeva, partner, Gorodissky
15:30 Digital era and evolution of life sciences
• Adapting your strategy for today’s competitive pharmaceuticalmarket
• Protecting and developing your assets in a digital world• Implications of AI and how it is being used to advance drug
treatments• Collaborating with outside counsel to manage uncertainty and
prepare for changes ahead
Rachel Wallis, partner, Greaves Brewster (moderator) Axel Ferrazzini, managing director, 4ip CouncilChris Wright, invention developer, Iprova
16:10 Close of conference
EUROPEAN L IFE SCIENCESFORUM 2018APRIL 24, LE MÉRIDIEN PICCADILLY LONDON
Booking fee Advisers, consultants,private practice, serviceproviders
In-house IP counsel, R&Dmanagers and heads oflegal
Early booking rate (before 2 March)
£695 + VAT FREE
Standard booking rate (after 2 March)
£895 + VAT FREE
Delegate 1
Name:
Job title:
Company:
Address:
Postcode:
Country:
Tel:
Email:
Delegate 2
Name:
Job title:
Company:
Address:
Postcode:
Country:
Tel:
Email:
1|Register (Please tick one box)
2|Your details for registration (Please print)
I cannot attend but please add me to your mailing list for future events.
3|Method of payment
+20% VAT TOTAL REMITTANCE
Onlinewww.managingip.com/EULIFESCIENCES2018
Telephone+44 (0) 20 7779 8938
MailKevin Pragas
Legal Media Group8 Bouverie Street
London, EC4Y 8AX, UK
CANCELLATION POLICY: By registering for this event, youare agreeing to the terms and conditions whereby youare liable for the full conference fee. All cancellationsmust be received in writing no later than 6 weeks beforethe first day of the event (15 March 2018) for a fullrefund less a 10% administration charge. We cannotaccept verbal cancellations. Cancellations received after 15 March 2018 are liablefor the full conference fee. Substitutions can be sent toattend in your place at no extra charge, however wemust know by 20 April 2018. If owing to a forcemajeure, Managing IP is obliged to postpone or cancelthe event, Managing IP will not be liable for any travel oraccommodation expenses incurred by delegates or theirorganisations.Badge swapping with other registered/non-registered del-egates is against our company policy and will not be per-mitted.
REGISTRATION FEE: The registration fee includes participa-tion in the forum, documentation material, breakfast, coffeebreaks and lunch. All delegates are responsible for theirown accommodation and travel.
PAYMENT: All registration fees (where applicable) must bereceived in full prior to the event date.
The information you provide on this form will be used byEuromoney Institutional Investor PLC and its group compa-nies (“we” or “us”) to process your order and deliver therelevant products/services. We may also monitor your useof the website(s) relating to your order, including informa-tion you post and actions you take, to improve our servicesand track compliance with our terms of use. Except to theextent you indicate your objection below, we may also useyour data (including data obtained from monitoring) (a) tokeep you informed of our products and services; (b) occa-sionally to allow companies outside our group to contactyou with details of their products/services; or (c) for ourjournalists to contact you for research purposes. As aninternational group, we may transfer your data on a globalbasis for the purposes indicated above, including to coun-tries which may not provide the same level of protection topersonal data as within the European Union. By submittingthis order, you will be indicating your consent to the use ofyour data as identified above. Further detail on our use ofyour personal data is set out in our privacy policy, which isavailable at www.euromoneyplc.com or can be providedto you separately upon request.If you object to contact by telephone , fax , or email, or post , please tick the relevant box. If you do notwant us to share your information with our journalists , orother companies please tick the relevant box.
To Register
Please tick the appropriate box to choose your payment method and signbelow:
Bank Transfer (details will be provided by invoice)
Credit Card Payment
REGISTRATION FEE: The registration fee includes participation in the forum, documentation material, breakfast,coffee breaks and lunch. All delegates are responsible for their own accommodation and travel.
PAYMENT: All registration fees (where applicable) must be received in full prior to the event date or the invoicedue date, whichever is sooner.
To make a payment by credit card, please register and pay online at:www.managingip.com/eulifesciences18 or call +44 (0) 20 7779 8938
Please note that in completing this booking form you undertake to adhere to the cancellation andpayment terms listed opposite.
Signature: Date:
Position:
